跳至主要内容
临床试验/NCT01148030
NCT01148030终止不适用

Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change

3M1 个研究点 分布在 1 个国家目标入组 333 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
3M
入组人数
333
试验地点
1
主要终点
Surgical Site Infection

研究概览

简要总结

Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery. After surgery, the subjects will be observed for any surgical site infections.

详细描述

Infection rate study.

研究设计

研究类型
Observational

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will be enrolled in the study.

排除标准

  • 未提供

研究组 & 干预措施

Single

3M Skin and Nasal Antiseptic

干预措施: 3M Skin and Nasal Antiseptic (Drug)

结局指标

主要结局

Surgical Site Infection

时间窗: 1 year after surgery

次要结局

未报告次要终点

研究者

发起方
3M
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验